Company intelligence / Profile preview

POROUS

Berlin, Berlin or Brandenburg region, Germanyporous.care ↗

Ownership: Private
Development stage: Commercial

Overview

POROUS has developed a patented, AI-based quantitative ultrasound platform for non-invasive bone quality and osteoporosis diagnosis. The technology enables earlier and more precise detection of osteoporosis compared to traditional X-ray methods. It has received the Berlin Brandenburg Innovation Award 2023 for its impact on early fracture risk assessment and is advancing toward clinical application.

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Medical Imaging

Partnerships

Centre for Muscle and Bone Research at Charité – Universitätsmedizin BerlinSuisag (Swiss breeding company)FBN Dummerstorf (“PigBoneS” project)

Beyond the preview

Go deeper on POROUS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on POROUS.

Explore the full profile